These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 32011968)
1. Changes in Concurrent Opioid and Benzodiazepine Use Following a Low-Touch Prescriber Fax Intervention. Yang R; Carruth SE; Qiu WA; Leslie RS J Manag Care Spec Pharm; 2020 Feb; 26(2):160-167. PubMed ID: 32011968 [TBL] [Abstract][Full Text] [Related]
2. Effectiveness of a Retrospective Drug Utilization Review on Potentially Unsafe Opioid and Central Nervous System Combination Therapy. Qureshi N; Wesolowicz LA; Liu CM; Tungol Lin A J Manag Care Spec Pharm; 2015 Oct; 21(10):938-44. PubMed ID: 26402392 [TBL] [Abstract][Full Text] [Related]
3. The Effect of a Federal Controlled Substance Act Schedule Change on Hydrocodone Combination Products Claims in a Medicaid Population. Tran S; Lavitas P; Stevens K; Greenwood BC; Clements K; Alper CJ; Lenz K; Price M; Hydery T; Arnold JL; Takeshita M; Bacon R; Peristere JP; Jeffrey PL J Manag Care Spec Pharm; 2017 May; 23(5):532-539. PubMed ID: 28448772 [TBL] [Abstract][Full Text] [Related]
4. Risk Factors and Outcomes of Opioid Users with and Without Concurrent Benzodiazepine Use in the North Carolina Medicaid Population. Hung A; Bush C; Greiner M; Campbell H; Hammill B; Maciejewski ML; McKethan A J Manag Care Spec Pharm; 2020 Feb; 26(2):169-175. PubMed ID: 32011957 [TBL] [Abstract][Full Text] [Related]
5. Incremental Effect of the Addition of Prescriber Restrictions on a State Medicaid's Pharmacy-Only Patient Review and Restriction Program. Keast SL; Pham T; Teel A; Nesser NJ J Manag Care Spec Pharm; 2017 Aug; 23(8):875-883. PubMed ID: 28737989 [TBL] [Abstract][Full Text] [Related]
7. Effect of Controlled Substance Use Management on Prescribing Patterns and Health Outcomes Among High-Risk Users. Chen X; Ma Q; Barron J; DeVries A; Horn J; Agiro A J Manag Care Spec Pharm; 2019 Mar; 25(3):392-401. PubMed ID: 30816820 [TBL] [Abstract][Full Text] [Related]
8. Assessment of Prescriber and Pharmacy Shopping Among the Family Members of Patients Prescribed Opioids. Chua KP; Brummett CM; Conti RM; Haffajee RL; Prosser LA; Bohnert ASB JAMA Netw Open; 2019 May; 2(5):e193673. PubMed ID: 31074819 [TBL] [Abstract][Full Text] [Related]
9. An Evaluation of a Multidisciplinary Pediatric Behavioral Health Medication Initiative Workgroup's Interventions on Medication Prescribing in a Population of Medicaid Patients. Chiara AN; Kashalikar N; Pomfret TC; Lenz K; Faber DM; Goldstein J; Clements KM; Angelini MC; Leto P; Jeffrey PL J Manag Care Spec Pharm; 2018 Aug; 24(8):746-751. PubMed ID: 30058981 [TBL] [Abstract][Full Text] [Related]
10. A Multichannel Medication Adherence Intervention Influences Patient and Prescriber Behavior. Leslie RS; Gilmer T; Natarajan L; Hovell M J Manag Care Spec Pharm; 2016 May; 22(5):526-38. PubMed ID: 27123914 [TBL] [Abstract][Full Text] [Related]
11. Opioid Use for Pain Management After Implementation of a Medicaid Short-Acting Opioid Quantity Limit. Riggs CS; Billups SJ; Flores S; Patel RJ; Heilmann RM; Milchak JL J Manag Care Spec Pharm; 2017 Mar; 23(3):346-354. PubMed ID: 28230448 [TBL] [Abstract][Full Text] [Related]
12. Health Care Burden Associated with Outpatient Opioid Use Following Inpatient or Outpatient Surgery. Brummett CM; England C; Evans-Shields J; Kong AM; Lew CR; Henriques C; Zimmerman NM; Pawasauskas J; Oderda G J Manag Care Spec Pharm; 2019 Sep; 25(9):973-983. PubMed ID: 31313621 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of prescriber responses to pharmacist recommendations communicated by fax in a medication therapy management program (MTMP). Perera PN; Guy MC; Sweaney AM; Boesen KP J Manag Care Pharm; 2011 Jun; 17(5):345-54. PubMed ID: 21657804 [TBL] [Abstract][Full Text] [Related]
15. Benzodiazepine prescribing patterns and deaths from drug overdose among US veterans receiving opioid analgesics: case-cohort study. Park TW; Saitz R; Ganoczy D; Ilgen MA; Bohnert AS BMJ; 2015 Jun; 350():h2698. PubMed ID: 26063215 [TBL] [Abstract][Full Text] [Related]
16. Association Between Receipt of Overlapping Opioid and Benzodiazepine Prescriptions From Multiple Prescribers and Overdose Risk. Chua KP; Brummett CM; Ng S; Bohnert ASB JAMA Netw Open; 2021 Aug; 4(8):e2120353. PubMed ID: 34374769 [TBL] [Abstract][Full Text] [Related]
17. An Examination of Concurrent Opioid and Benzodiazepine Prescribing in 9 States, 2015. Guy GP; Zhang K; Halpin J; Sargent W Am J Prev Med; 2019 Nov; 57(5):629-636. PubMed ID: 31564606 [TBL] [Abstract][Full Text] [Related]
18. Impact of community pharmacist intervention on concurrent benzodiazepine and opioid prescribing patterns. Luchen GG; Prohaska ES; Ruisinger JF; Melton BL J Am Pharm Assoc (2003); 2019; 59(2):238-242. PubMed ID: 30552053 [TBL] [Abstract][Full Text] [Related]
19. Opioid Treatment Patterns Following Prescription of Immediate-Release Hydrocodone. Ben-Joseph R; Bell JA; Brixner D; Kansal A; Paramore C; Chitnis A; Holly P; S Burgoyne D J Manag Care Spec Pharm; 2016 Apr; 22(4):358-66. PubMed ID: 27023689 [TBL] [Abstract][Full Text] [Related]
20. Safer and more appropriate opioid prescribing: a large healthcare system's comprehensive approach. Losby JL; Hyatt JD; Kanter MH; Baldwin G; Matsuoka D J Eval Clin Pract; 2017 Dec; 23(6):1173-1179. PubMed ID: 28707421 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]